Table 2 Characteristics of the mediastinal and hilar adenopathies.
From: Validity and reliability of transbronchial needle aspiration for diagnosing mediastinal adenopathies
Pathology | Lymph nodes examined | Lymph nodes per patient# | Passes# | Lymph node size, mm# |
|---|---|---|---|---|
Non-small cell lung carcinoma | 314 | 1.0 (1-2) | 2.0 (1-5) | 19.0 (10-85) |
Small cell lung carcinoma | 78 | 1.0 (1-2) | 2.0 (1-6) | 28.5 (10-79) |
Extrapulmonary carcinoma | 55 | 1.0 (1-3) | 2.0 (1-6) | 21.0 (10-42) |
Sarcoidosis | 82 | 1.0 (1-3) | 3.0 (1-4) | 20.0 (10-45) |
Tuberculosis | 27 | 1.0 (1-2) | 3.0 (2-4) | 20.0 (10-39) |
Lymphoma | 20 | 1.0 (1-2) | 3.0 (2-5) | 23.0 (10-41) |
Anthracotic and reactive | 109 | 1.0 (1-3) | 3.0 (1-6) | 15.0 (10-59) |
Total | 685 | 1.0 (1-3) | 2.0 (1-6) | 20.0 (10-85) |